Diseases, Conditions, Syndromes

AstraZeneca agrees to make COVID-19 vaccine for Europe

Drugmaker AstraZeneca struck a deal Saturday to supply up to 400 million doses of an experimental COVID-19 vaccine to European Union countries, the latest in a series of agreements as scientists, governments and pharmaceutical ...

Diseases, Conditions, Syndromes

Study confirms longer-term lung damage after COVID-19

A study by Sheffield and Oxford researchers using a cutting-edge method of imaging has identified persistent damage to the lungs of COVID-19 patients at least three months after they were discharged from hospital, and for ...

Ophthalmology

Gene therapy shows promise for reversing blindness

Most causes of untreatable blindness occur due to loss of the millions of light sensitive photoreceptor cells that line the retina, similar to the pixels in a digital camera.

Neuroscience

Tiny mesh tube devices to treat brain aneurysms

An Oxford spin-out is developing advanced tiny metallic mesh tube devices invented by engineers and clinicians at the University to treat patients suffering from brain aneurysms.

page 1 from 4